We are thrilled to bring a unique combination of academic excellence, entrepreneurial success, and investment expertise to our team.

‍

Dr. Talia's academic foundation includes a PhD from Stockholm School of Economics, followed by a Postdoctoral Fellowship at Harvard University's Department of Economics. This strong theoretical background has been complemented by significant leadership roles in Sweden's innovation ecosystem, most notably as Vice President Health and Lifescience at RISE - Research Institutes of Sweden, the country's largest government-owned research institute reporting to the Ministry of Enterprise and Innovation.

‍

His operational expertise spans both incubation and acceleration, having served as CEO of Sting, one of the world's leading incubators and accelerators based in Stockholm. This experience provided him with deep insights into scaling early-stage companies and navigating the challenges faced by entrepreneurs in their growth journey.

‍

As a serial entrepreneur, Dr. Talia has demonstrated remarkable success across multiple industries. His co-founded companies include Nanologica AB (publicly listed), the innovative solar technology company Exeger AB, Depalma Work Wear, Zibetto Holding, and the New York-based Zibetto Espresso Bars Inc. This diverse portfolio showcases his ability to identify opportunities and build successful businesses across different sectors and geographies.

‍

Dr. Talia's investment experience is equally impressive. As founder and sole owner of 3TInvest, he has established himself as one of Sweden's most active pre-seed and seed round investors, with a track record of identifying and supporting promising startups at their earliest stages. Currently serving as Director of Investments at Super Human Network's world-leading longevity initiative, he continues to be at the forefront of emerging technologies and investment trends.

‍

His combination of scientific rigor, entrepreneurial instinct, and investment acumen makes him an invaluable addition to Pinecone Ventures as we continue to support exceptional founders and breakthrough technologies.